CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
simvastatindrug
Likely dose
Simvastatin 5-10 mg/day orallyAI-extracted
Key inclusion· 2
  • ✓Carotid atherosclerosis detected by carotid ultrasound (Protocol 1)
  • ✓Vascular FDG uptakes on prior cancer screening FDG-PET (Protocol 2)
Key exclusion· 7
  • ✕Active inflammatory diseases
  • ✕Dyslipidemia under medications
  • ✕Uncontrolled diabetes mellitus
  • ✕Vasculitis

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00114504
NCT00114504N/ACompleted
CompareCT.gov

Detection of Atherosclerotic Plaque Inflammation and Visualization of Anti-inflammatory Effects of Statins on Plaque Inflammation by FDG-PET

Kurume University·interventional·Posted Jun 16, 2005·Updated Jun 1, 2015

In Brief

A clinical study evaluating simvastatin for Atherosclerosis. Completed, enrolled 43 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether FDG-PET is capable of detecting atherosclerotic plaque inflammation and monitoring the effects of statins on plaque inflammation. The usefulness of FDG-PET in risk stratification is also investigated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 16, 2005
Enrollment StartSep 1, 2004
Primary CompletionApr 1, 2007
Study CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 21.0 years ago

Interventions

simvastatindrug

simvastatin 5-10 mg/day